Skip to search formSkip to main contentSkip to account menu

elotuzumab

Known as: anti-CS1 monoclonal antibody HuLuc63, HuLuc63, Immunoglobulin G1, anti-(human SLAM family member 7 (CD2-like receptor activating cytotoxic cells, CD319 antigen)), humanized mouse monoclonal HuLuc63 gamma-1 heavy chain (222-214')-disulfide with humanized mouse monoclonal HuLuc63 kappa light chain (228-228'';231-231'')-bisdisulfide dimer 
A humanized monoclonal antibody directed against the human CS1 (CD2 subset 1, CRACC, SLAMF7) antigen with potential antineoplastic activity… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Background. This study aimed to determine the progression-free survival and response rate using early therapeutic intervention… 
2017
2017
The discovery of new targets for tailored therapy is a major improvement in oncology, and tools for the rapid and reliable… 
2015
2015
Este artigo apresenta uma revisao sistematica da literatura (RSL) sobre o ensino de programacao e algoritmos para alunos… 
2015
2015
Introduction: Elotuzumab, an immunostimulatory monoclonal antibody, recognizes Signaling Lymphocytic Activation Molecule F7… 
2015
2015
Introduction: Elotuzumab is an immunostimulatory monoclonal antibody (mAb) that recognizes Signaling Lymphocytic Activation… 
Review
2014
Review
2014
During the past decade, overall results of treatment of multiple myeloma (MM) have been improved and survival curves are now… 
Review
2013
Review
2013
Many advances in the treatment of multiple myeloma have been made due to the use of transplantation and the introduction of novel… 
2013
2013
We present examples of exotic structures on $$pP_\mathbb{C}^2 \# q\overline {P_\mathbb{C}^2 }$$ for some small p and q obtained… 
2009
2009
The effectiveness of vehicle weight estimations from bridge weigh-in-motion system is studied. The measured bending moments of…